Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
150 participants
INTERVENTIONAL
2025-01-06
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that participants randomized to receive YPRx plus DPP will have greater weight loss, increased physical activity, improved diet quality and behaviors, increased food security, improved self-rated health assessment, decreased healthcare utilization from baseline to endline (12 months) compared to those randomized to receive YPRx produce deliveries only.
We will also collect data on process measures for implementation purposes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Community Health Worker Strategy on Produce Prescription Program Uptake Among People With Diabetes
NCT06401668
Iowa Produce Prescription Program
NCT06837805
Pathway for Produce Prescriptions in Diabetes Management
NCT06058338
BRInging the Diabetes Prevention Program to GEriatric Populations
NCT05166785
A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes
NCT05939349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Produce Rx Program Only (Control)
YMCA Produce Prescription Program deliveries of fresh produce bags once per week for 52 weeks.
YMCA Produce Rx (YPRx) Program Only (Control)
Participants in the control group will receive weekly, home-delivered produce bags of fresh vegetables and fruits and sized for each participants' household. Produce deliveries will be administered for 52 weeks.
Produce Rx Program + Diabetes Prevention Program
YMCA Produce Prescription Program deliveries of fresh produce bags once per week for 52 weeks plus the Diabetes Prevention Program via 26 virtual coaching and support sessions over 12 months.
YMCA Produce Rx (YPRx) Program + the Diabetes Prevention Program (DPP)
Participants will receive weekly, home-delivered produce bags of fresh vegetables and fruits and sized for each participants' household. Produce deliveries will be administered for 52 weeks. Additionally, participants will be registered for a free, year-long YMCA membership and enrolled in the DPP. Through the DPP, participants will receive health education, coaching, and peer support via 26 virtual group sessions over a year.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
YMCA Produce Rx (YPRx) Program Only (Control)
Participants in the control group will receive weekly, home-delivered produce bags of fresh vegetables and fruits and sized for each participants' household. Produce deliveries will be administered for 52 weeks.
YMCA Produce Rx (YPRx) Program + the Diabetes Prevention Program (DPP)
Participants will receive weekly, home-delivered produce bags of fresh vegetables and fruits and sized for each participants' household. Produce deliveries will be administered for 52 weeks. Additionally, participants will be registered for a free, year-long YMCA membership and enrolled in the DPP. Through the DPP, participants will receive health education, coaching, and peer support via 26 virtual group sessions over a year.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recipient of Medicaid through Amerigroup
* Has never been diagnosed with type I or type II diabetes
* Access to laptop, computer, or phone with internet, or willing to use a provided device
* District of Columbia resident
* Available to attend DPP classes at the scheduled recurring day and time
* Not pregnant
Exclusion Criteria
* Not a recipient of Medicaid through Amerigroup
* Has been diagnosed with type I or type II diabetes
* No access to laptop, computer, or phone with internet
* Not a resident of the District of Columbia
* Cannot attend DPP classes at the scheduled recurring day and time
* Pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AmeriGroup
UNKNOWN
Hungry Harvest
UNKNOWN
Johns Hopkins Bloomberg School of Public Health
OTHER
Elevance Health
INDUSTRY
Tessa Mork
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tessa Mork
Association Director of Community Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristy McCarron, MPH
Role: PRINCIPAL_INVESTIGATOR
YMCA of Metropolitan Washington
Julia Wolfson, PhD MPP
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins Bloomberg School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
YMCA of Metropolitan Washington
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tessa Mork
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-70424-38459
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
00022594
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.